NCT03482466

Brief Summary

A commonly used therapy for post-traumatic stress disorder (PTSD) that often (but not always) gives good results is "exposure therapy": When the patient (for example, Veterans who have attacks of anxiety when a noise startles them) talks about the trauma that precipitated the PTSD, she or he slowly becomes less sensitive to PTSD. This works only on some patients. The investigators propose to expose PTSD patients to a number of "training" sessions in which they will be in a virtual world (similar to a video game) driving a car through a place resembling Iraq. This will happen inside an MRI machine, and the investigators will obtain brain images while the patient is exploring the "virtual Iraq" environment. The investigators will project on the screen a bar that will let the patient know, in real time, which is the state of her or his brain, from CALM to STRESS. The job of the patient will be to try to come up with personal strategies (breathe slowly, think calming thoughts) to try to bring the bar to CALM. The investigators believe that after a number of sessions, the patient will be able to create personalized mental strategies to bring their brain to CALM state, even in real life. This could become a much stronger way of performing "exposure therapy". Finally, the investigators will use a wearable device (similar to a wristwatch) to be able to study physical activity and sleep patters in PTSD patients through the training, in the hope that the investigators may find a way to objectively study when a patient is doing better.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 16, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 29, 2018

Completed
7 months until next milestone

Study Start

First participant enrolled

November 1, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 14, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 24, 2020

Completed
3.6 years until next milestone

Results Posted

Study results publicly available

June 28, 2024

Completed
Last Updated

June 28, 2024

Status Verified

March 1, 2024

Enrollment Period

1.8 years

First QC Date

March 16, 2018

Results QC Date

February 16, 2022

Last Update Submit

March 5, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • CAPS-5 PTSD Criteria

    Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) is a 30-item structured interview that can be used to determine: current (past month) diagnosis of PTSD, lifetime diagnosis of PTSD, PTSD symptoms over the past week. Scores range from 0 - 80, with higher scores indicating increased PTSD symptom severity. The full interview takes 45-60 minutes to administer. In addition to PTSD symptoms, questions target symptom onset and duration, subjective distress, impact of symptoms on social and occupational functioning, overall response validity, overall PTSD severity, and specifications for the dissociative subtype (depersonalization and derealization). The CAPS-5 produces reliable and valid scores with standard administration. It should be administered by qualified interviewers with formal training in structured clinical interviewing and differential diagnosis, a thorough understanding of the conceptual basis of PTSD, and detailed knowledge of the measure's features and conventions.

    6 weeks

Secondary Outcomes (3)

  • Wearable Device Data: Heart Rate

    Change from baseline at 6 weeks

  • Wearable Device Data: Sleep Patterns

    Change from baseline at 6 weeks

  • Wearable Device Data: Total Sleep

    Change from baseline at 6 weeks

Study Arms (1)

PTSD patients

EXPERIMENTAL

12 PTSD patients will be recruited to undergo neurofeedback training .

Behavioral: Neurofeedback

Interventions

NeurofeedbackBEHAVIORAL

Patients will be inside an MRI machine. They will be trained using real time feedback from brain imaging to learn personal strategies to bring their brain to the CALM state.

Also known as: Real time fMRI virtual reality training
PTSD patients

Eligibility Criteria

Age18 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Meet CAPS5 PTSD criteria
  • OEF/OIF/OND \& PGW Veterans
  • Seeking treatment for PTSD

You may not qualify if:

  • DSM-5 criteria for drug or alcohol abuse or dependence in past 30 days
  • History of moderate to severe traumatic brain injury
  • Presence of contraindications to MRI
  • Current neurological or general medical conditions known to impact cognitive and/or emotional functioning (epilepsy, Parkinson's, etc.)
  • Acute psychological instability, schizophrenia, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Michael E. DeBakey VA Medical Center, Houston, TX

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

Neurofeedback

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Biofeedback, PsychologyMind-Body TherapiesComplementary TherapiesTherapeuticsBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesFeedback, Psychological

Limitations and Caveats

Due to unforeseen circumstances including COVID-19, we were unable to complete the whole project.

Results Point of Contact

Title
Ramiro Salas
Organization
Baylor College of Medicine; Michael E. DeBakey VA Medical Center; Menninger Clinic

Study Officials

  • Ramiro Salas, PhD

    Michael E. DeBakey VA Medical Center, Houston, TX

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: 12 PTSD patients will be exposed to the real time functional MRI neurofeedback training. The investigators will assess PTSD symptoms both clinically and with a "take home" wearable device that will collect data on physical activity, heart rate, and sleep patterns.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 16, 2018

First Posted

March 29, 2018

Study Start

November 1, 2018

Primary Completion

August 14, 2020

Study Completion

November 24, 2020

Last Updated

June 28, 2024

Results First Posted

June 28, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations